Effects of recombinant human canstatin protein in the treatment of pancreatic cancer - Wikidata - awgldk - TriplyDB

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

http://www.wikidata.org/entity/Q34017753

about

Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.Endogenous Matrix-Derived Inhibitors of Angiogenesis.

P2860

Q54569237-839851CC-5B06-4C22-91EE-08CB7A85F195 Q55506580-FAE23C2B-3D60-4A02-A3BA-55CDDDE96704

P2860

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

http://www.wikidata.org/entity/Q34017753

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

@ast

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

@en

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

@nl

type

label

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

@ast

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

@en

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

@nl

prefLabel

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

@ast

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

@en

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

@nl

P1433

Q34017753-3DC63F90-6A12-44F8-B521-117C6D97F6D5

P1476

Q34017753-3E18E6C4-5483-4483-B373-B53462F7E5F5

P2093

Q34017753-0B07B2A3-63C1-41F9-92CD-76B077CDD80F

Q34017753-15141083-6AA6-49E9-A4AD-2AACB0843FF2

Q34017753-1A667618-A463-4F1A-A63A-4D46268571AC

Q34017753-21F7AC88-7E43-4312-B51F-B54D0BF73687

Q34017753-3578495C-B6F2-4B93-8508-06065421B856

Q34017753-40794663-87EB-4612-84F4-5F4701029F26

Q34017753-6100FD0E-85DF-46C1-8F3B-E8B7A781C2E3

Q34017753-6358D8BC-435D-499E-81DA-449731316A36

Q34017753-9207E702-9ED2-4CFD-AAAA-C1664824971C

Q34017753-D7ABF336-269D-451E-911A-D6DA381C1D55

P2860

Q34017753-0B9EFF82-ED2B-4A4E-9C10-2AB918C814CA

Q34017753-11F1CE45-24F4-49B0-ACF2-5C45B6280995

Q34017753-13891C45-9FBF-41FB-8FD9-86EC03CDF4E8

Q34017753-16462DA1-279B-469E-B3C0-7309DA4CADB7

Q34017753-29631797-DC36-4535-944D-DF99062A097C

Q34017753-3C268230-600F-461D-AB28-DF005EB5DB61

Q34017753-41B24D20-D073-487C-B80E-88CEC9C3ED70

Q34017753-46F226C5-EC4D-463D-B8DC-602B75FF9DFA

Q34017753-5351EB95-2AE4-4F41-B1DC-509F73674954

Q34017753-56747D43-8AE5-499E-9267-9491C8F30FC5

P304

Q34017753-3ACB5C11-AADA-40E3-B87A-31EA1B9E29B0

P31

Q34017753-C7DD1C93-F836-4998-93C4-801AB6CDAEE0

P356

Q34017753-142E19DA-32C5-42D4-B604-9D9BDEC3E5B7

P407

Q34017753-63D4F9B5-F131-4879-A661-73537DDA0C91

P433

Q34017753-894C6BB6-181A-4848-9464-213B767DBBD6

P478

Q34017753-C6384EA4-E8FA-4F08-932D-1989510E8BB0

P577

Q34017753-8B6A313F-ED17-4207-9AD9-DD71F2BDE10C

P5875

Q34017753-808D4F55-041D-462D-8796-647EFACF8CCB

P698

Q34017753-2FE10715-7C19-4D17-9412-0B9363B10051

P932

Q34017753-93FF5879-8BA4-4384-BB7A-D524A1F7D204

P356

WJG.V12.I41.6652

P1433

World Journal of Gastroenterology

P1476

Effects of recombinant human canstatin protein in the treatment of pancreatic cancer

@en

P2093

Ai-Fang Xu

http://www.w3.org/2001/XMLSchema#string

Hong-Yu Wu

http://www.w3.org/2001/XMLSchema#string

Jing Jin

http://www.w3.org/2001/XMLSchema#string

Jun Gao

http://www.w3.org/2001/XMLSchema#string

Ren-Min Zhu

http://www.w3.org/2001/XMLSchema#string

Xiao-Hua Man

http://www.w3.org/2001/XMLSchema#string

Xiao-Ping He

http://www.w3.org/2001/XMLSchema#string

Xue Pan

http://www.w3.org/2001/XMLSchema#string

Yan-Fang Gong

http://www.w3.org/2001/XMLSchema#string

Zhao-Shen Li

http://www.w3.org/2001/XMLSchema#string

P2860

Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Angiogenesis in life, disease and medicine

Basement membranes: structure, assembly and role in tumour angiogenesis

Novel method for expression and purification of human pigment epithelium-derived factor with biological activities in Escherichia coli.

Antiangiogenesis therapy. Current and future agents.

Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.

Novel therapies for renal cell carcinoma--an update.

Kringle structures and antiangiogenesis.

Surrogate markers in antiangiogenesis clinical trials.

P304

6652-6657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V12.I41.6652

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

298735422

http://www.w3.org/2001/XMLSchema#string

P698

17075979

http://www.w3.org/2001/XMLSchema#string

P932

4125671

http://www.w3.org/2001/XMLSchema#string